Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis.

Al-Fayoumi S, Hashiguchi T, Shirakata Y, Mascarenhas J, Singer JW.

Open source

DOI
10.2147/jep.s150729
Published
2018-05-09
Container
J Exp Pharmacol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/jep.s150729,
  title = {Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis.},
  author = {Al-Fayoumi S and  Hashiguchi T and  Shirakata Y and  Mascarenhas J and  Singer JW.},
  year = {2018},
  journal = {J Exp Pharmacol},
  doi = {10.2147/jep.s150729},
  url = {https://doi.org/10.2147/jep.s150729}
}

RIS

TY  - JOUR
TI  - Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis.
AU  - Al-Fayoumi S
AU  -  Hashiguchi T
AU  -  Shirakata Y
AU  -  Mascarenhas J
AU  -  Singer JW.
PY  - 2018
JO  - J Exp Pharmacol
DO  - 10.2147/jep.s150729
UR  - https://doi.org/10.2147/jep.s150729
ER  - 

APA

S, A., T, H., Y, S., J, M., & JW., S. (2018). Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis.. J Exp Pharmacol. https://doi.org/10.2147/jep.s150729

Source records